Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...

Abbott introduced a revolutionary new device, FreeStyle Navigator, designed to improve the lives of the world’s more than 500 ...

Abbott announced the findings of a new survey; among leading infectious disease experts around the world on the state of ...

In the latest market close, Abbott (ABT) reached $113.70, with a -0.39% movement compared to the previous day. This move lagged the S&P 500's daily loss of 0.19%. Meanwhile, the Dow experienced a rise ...

Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report), ...

O'Melveny & Myers is defending Abbott Laboratories in a pending class action against the company and two other co-defendants, ...

Piper Sandler initiates coverage on Abbott with an Overweight rating, citing its diversified business model, strong medtech ...

Abbott’s over-the-counter continuous glucose monitor is now available in the US. There’s an affiliated app that shows graphs ...

Texas Gov. Greg Abbott wants the feds to pay more for undocumented immigrants' medical care. Here's an easy place to start.

Texas hospitals who are enrolled in state health plans, Medicaid and the Children's Health Insurance Program will start ...

Governor Abbott appoints four members, including Laurel Simmons and Rajesh Shenava, to Texas Medical Board's District One ...